CLINICAL_TRIALS
trial_result
· 2018-04-17
Clinical Trial Update: Belimumab in Remission of VASculitis [Phase 3]
Summary
A Phase 3 trial evaluating belimumab for inducing remission in vasculitis has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Vasculitis | Phase 3 | Status: COMPLETED | Results posted: 2018-04-17